Year: 2024
Type: review
Abstract: There is a high prevalence of genetic abnormalities that significantly contribute to overall morbidity and mortality in neonates. Since early diagnosis is crucial for the optimal administration of conventional and customized medications, neonatal acute care has the most significant potential to benefit from genomic medicine. Genome sequencing has been demonstrated to have diagnostic, therapeutic and informational value in many investigations. With underlying genetic disorders, genome sequencing has the power to change the way newborn care is provided completely. However, due to existing healthcare disparities, genomic medicine requires cautious implementation to guarantee equitable access for disadvantaged groups. Hence, its clinical application is still challenging.
Source: OBM Genetics
Language: English
Topic: Genomics and Rare Diseases
Subfield: Genetics
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W4405650196